Rubedo Life Sciences has just announced positive early results from its first human clinical trial of anti-aging treatment, RLS-1496. The biotech company said the drug worked “even better than should ...
Explore detailed information about 1496's dividend performance, find the 1496 dividend history and ex-dividend date. This page offers a comprehensive view of 1496's dividend yield payout trends and ...
First patient dosed with topical RLS-1496 in clinical trial will assess the safety and clinical effects of single and multiple doses to treat adults with mild to moderate and stable plaque psoriasis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results